NCBI PubMed Centralopen access
Astragaloside IV and rapamycin co-loaded bone marrow mesenchymal stem cell-derived exosome nanocarriers for targeted modulation of the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.
distributed systems architecture
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 645444
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.